Table 1. Susceptibility testing of presented case.
Drug | MIC | Interpretation |
Amikacin | > 32 | R |
Ampicillin/Sulbactam | > 16/8 | R |
Ampicillin | > 16 | R |
Cefepime | > 16 | R |
Cefotaxime | > 32 | R |
Cefoxitin | > 8 | R |
Ceftazidime | > 16 | R |
Cefuroxime | > 16 | R |
Ciprofloxacin | > 2 | R |
Ertapenem | > 1 | R |
Fosfomycin | > 64 | R |
Gentamycin | > 8 | R |
Imipenem | > 8 | R |
Levofloxacin | > 4 | R |
Meropenem | > 8 | R |
Moxifloxacin | > 1 | R |
Nalidixic Acid | > 16 | R |
Nitrofurantoin | > 64 | R |
Piperacillin/Tazobactam | > 64 | R |
Piperacillin | > 64 | R |
Tetracycline | > 8 | R |
Tigecycline | ≤ 2 | S |
Tobramycin | > 8 | R |
Trimethoprim/Sulfamethoxazole | > 4/76 | R |
S = Susceptible I = Intermediate R = Resistant MIC = mcg/ml (mg/L) |